ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Non-Invasive Prenatal Testing Market Insights, Forecast to 2029
Published Date: August 2023
|
Report Code: QYRE-Auto-29Y3959
Home | Market Reports | Health| Reproductive Health
Global Non Invasive Prenatal Testing Market Insights and Forecast to 2028
BUY CHAPTERS

Global Non-Invasive Prenatal Testing Market Insights, Forecast to 2029

Code: QYRE-Auto-29Y3959
Report
August 2023
Pages:95
QYResearch
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sequenom
Roche
Natera
LabCorp
BGI Genomics
Quest Diagnostics
Illumina Inc
Berry Genomics

Non-Invasive Prenatal Testing Market Size

The global Non-Invasive Prenatal Testing market is projected to grow from US$ 5472.5 million in 2023 to US$ 10060 million by 2029, at a Compound Annual Growth Rate (CAGR) of 10.7% during the forecast period.

Non-Invasive Prenatal Testing Market

Non-Invasive Prenatal Testing Market

Non-Invasive Prenatal Testing is a method of determining the risk that the fetus will be born with certain genetic abnormalities. This testing analyzes small fragments of DNA that are circulating in a pregnant woman's blood
Market Analysis and Insights: Global Non-Invasive Prenatal Testing Market
The US & Canada market for Non-Invasive Prenatal Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Non-Invasive Prenatal Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Non-Invasive Prenatal Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key companies of Non-Invasive Prenatal Testing include Sequenom, Roche, Natera, LabCorp, BGI Genomics, Quest Diagnostics, Illumina and Berry Genomics, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Non-Invasive Prenatal Testing market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Non-Invasive Prenatal Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Non-Invasive Prenatal Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Non-Invasive Prenatal Testing revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Non-Invasive Prenatal Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Non-Invasive Prenatal Testing revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sequenom, Roche, Natera, LabCorp, BGI Genomics, Quest Diagnostics, Illumina and Berry Genomics, etc.

Scope of Non-Invasive Prenatal Testing Market Report

Report Metric Details
Report Name Non-Invasive Prenatal Testing Market
Accounted market size in 2023 US$ 5472.5 in million
Forecasted market size in 2029 US$ 10060 million
Base Year 2023
Forecasted years 2023 - 2029
Segment by Type
  • High & Average Risk
  • Low Risk
Segment by Application
  • 0-12 Weeks
  • 13-24 Weeks
  • 25-36 Weeks
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sequenom, Roche, Natera, LabCorp, BGI Genomics, Quest Diagnostics, Illumina, Berry Genomics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Non-Invasive Prenatal Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Non-Invasive Prenatal Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America by type, by application and by country, revenue for each segment.
  • Chapter 7: Europe by type, by application and by country, revenue for each segment.
  • Chapter 8: China by type and by application revenue for each segment.
  • Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-Invasive Prenatal Testing revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-Invasive Prenatal Testing Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 High & Average Risk
1.2.3 Low Risk
1.3 Market by Application
1.3.1 Global Non-Invasive Prenatal Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 0-12 Weeks
1.3.3 13-24 Weeks
1.3.4 25-36 Weeks
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Non-Invasive Prenatal Testing Market Perspective (2018-2029)
2.2 Global Non-Invasive Prenatal Testing Growth Trends by Region
2.2.1 Non-Invasive Prenatal Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Non-Invasive Prenatal Testing Historic Market Size by Region (2018-2023)
2.2.3 Non-Invasive Prenatal Testing Forecasted Market Size by Region (2024-2029)
2.3 Non-Invasive Prenatal Testing Market Dynamics
2.3.1 Non-Invasive Prenatal Testing Industry Trends
2.3.2 Non-Invasive Prenatal Testing Market Drivers
2.3.3 Non-Invasive Prenatal Testing Market Challenges
2.3.4 Non-Invasive Prenatal Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Non-Invasive Prenatal Testing by Players
3.1.1 Global Non-Invasive Prenatal Testing Revenue by Players (2018-2023)
3.1.2 Global Non-Invasive Prenatal Testing Revenue Market Share by Players (2018-2023)
3.2 Global Non-Invasive Prenatal Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Non-Invasive Prenatal Testing, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Non-Invasive Prenatal Testing Market Concentration Ratio
3.4.1 Global Non-Invasive Prenatal Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-Invasive Prenatal Testing Revenue in 2022
3.5 Global Key Players of Non-Invasive Prenatal Testing Head office and Area Served
3.6 Global Key Players of Non-Invasive Prenatal Testing, Product and Application
3.7 Global Key Players of Non-Invasive Prenatal Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-Invasive Prenatal Testing Breakdown Data by Type
4.1 Global Non-Invasive Prenatal Testing Historic Market Size by Type (2018-2023)
4.2 Global Non-Invasive Prenatal Testing Forecasted Market Size by Type (2024-2029)
5 Non-Invasive Prenatal Testing Breakdown Data by Application
5.1 Global Non-Invasive Prenatal Testing Historic Market Size by Application (2018-2023)
5.2 Global Non-Invasive Prenatal Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Non-Invasive Prenatal Testing Market Size (2018-2029)
6.2 North America Non-Invasive Prenatal Testing Market Size by Type
6.2.1 North America Non-Invasive Prenatal Testing Market Size by Type (2018-2023)
6.2.2 North America Non-Invasive Prenatal Testing Market Size by Type (2024-2029)
6.2.3 North America Non-Invasive Prenatal Testing Market Share by Type (2018-2029)
6.3 North America Non-Invasive Prenatal Testing Market Size by Application
6.3.1 North America Non-Invasive Prenatal Testing Market Size by Application (2018-2023)
6.3.2 North America Non-Invasive Prenatal Testing Market Size by Application (2024-2029)
6.3.3 North America Non-Invasive Prenatal Testing Market Share by Application (2018-2029)
6.4 North America Non-Invasive Prenatal Testing Market Size by Country
6.4.1 North America Non-Invasive Prenatal Testing Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Non-Invasive Prenatal Testing Market Size by Country (2018-2023)
6.4.3 North America Non-Invasive Prenatal Testing Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Non-Invasive Prenatal Testing Market Size (2018-2029)
7.2 Europe Non-Invasive Prenatal Testing Market Size by Type
7.2.1 Europe Non-Invasive Prenatal Testing Market Size by Type (2018-2023)
7.2.2 Europe Non-Invasive Prenatal Testing Market Size by Type (2024-2029)
7.2.3 Europe Non-Invasive Prenatal Testing Market Share by Type (2018-2029)
7.3 Europe Non-Invasive Prenatal Testing Market Size by Application
7.3.1 Europe Non-Invasive Prenatal Testing Market Size by Application (2018-2023)
7.3.2 Europe Non-Invasive Prenatal Testing Market Size by Application (2024-2029)
7.3.3 Europe Non-Invasive Prenatal Testing Market Share by Application (2018-2029)
7.4 Europe Non-Invasive Prenatal Testing Market Size by Country
7.4.1 Europe Non-Invasive Prenatal Testing Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Non-Invasive Prenatal Testing Market Size by Country (2018-2023)
7.4.3 Europe Non-Invasive Prenatal Testing Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Non-Invasive Prenatal Testing Market Size (2018-2029)
8.2 China Non-Invasive Prenatal Testing Market Size by Type
8.2.1 China Non-Invasive Prenatal Testing Market Size by Type (2018-2023)
8.2.2 China Non-Invasive Prenatal Testing Market Size by Type (2024-2029)
8.2.3 China Non-Invasive Prenatal Testing Market Share by Type (2018-2029)
8.3 China Non-Invasive Prenatal Testing Market Size by Application
8.3.1 China Non-Invasive Prenatal Testing Market Size by Application (2018-2023)
8.3.2 China Non-Invasive Prenatal Testing Market Size by Application (2024-2029)
8.3.3 China Non-Invasive Prenatal Testing Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Non-Invasive Prenatal Testing Market Size (2018-2029)
9.2 Asia Non-Invasive Prenatal Testing Market Size by Type
9.2.1 Asia Non-Invasive Prenatal Testing Market Size by Type (2018-2023)
9.2.2 Asia Non-Invasive Prenatal Testing Market Size by Type (2024-2029)
9.2.3 Asia Non-Invasive Prenatal Testing Market Share by Type (2018-2029)
9.3 Asia Non-Invasive Prenatal Testing Market Size by Application
9.3.1 Asia Non-Invasive Prenatal Testing Market Size by Application (2018-2023)
9.3.2 Asia Non-Invasive Prenatal Testing Market Size by Application (2024-2029)
9.3.3 Asia Non-Invasive Prenatal Testing Market Share by Application (2018-2029)
9.4 Asia Non-Invasive Prenatal Testing Market Size by Region
9.4.1 Asia Non-Invasive Prenatal Testing Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Non-Invasive Prenatal Testing Market Size by Region (2018-2023)
9.4.3 Asia Non-Invasive Prenatal Testing Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Non-Invasive Prenatal Testing Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Non-Invasive Prenatal Testing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Non-Invasive Prenatal Testing Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Non-Invasive Prenatal Testing Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Non-Invasive Prenatal Testing Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Non-Invasive Prenatal Testing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Non-Invasive Prenatal Testing Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Non-Invasive Prenatal Testing Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Non-Invasive Prenatal Testing Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Non-Invasive Prenatal Testing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Non-Invasive Prenatal Testing Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Non-Invasive Prenatal Testing Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Non-Invasive Prenatal Testing Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Sequenom
11.1.1 Sequenom Company Details
11.1.2 Sequenom Business Overview
11.1.3 Sequenom Non-Invasive Prenatal Testing Introduction
11.1.4 Sequenom Revenue in Non-Invasive Prenatal Testing Business (2018-2023)
11.1.5 Sequenom Recent Developments
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Non-Invasive Prenatal Testing Introduction
11.2.4 Roche Revenue in Non-Invasive Prenatal Testing Business (2018-2023)
11.2.5 Roche Recent Developments
11.3 Natera
11.3.1 Natera Company Details
11.3.2 Natera Business Overview
11.3.3 Natera Non-Invasive Prenatal Testing Introduction
11.3.4 Natera Revenue in Non-Invasive Prenatal Testing Business (2018-2023)
11.3.5 Natera Recent Developments
11.4 LabCorp
11.4.1 LabCorp Company Details
11.4.2 LabCorp Business Overview
11.4.3 LabCorp Non-Invasive Prenatal Testing Introduction
11.4.4 LabCorp Revenue in Non-Invasive Prenatal Testing Business (2018-2023)
11.4.5 LabCorp Recent Developments
11.5 BGI Genomics
11.5.1 BGI Genomics Company Details
11.5.2 BGI Genomics Business Overview
11.5.3 BGI Genomics Non-Invasive Prenatal Testing Introduction
11.5.4 BGI Genomics Revenue in Non-Invasive Prenatal Testing Business (2018-2023)
11.5.5 BGI Genomics Recent Developments
11.6 Quest Diagnostics
11.6.1 Quest Diagnostics Company Details
11.6.2 Quest Diagnostics Business Overview
11.6.3 Quest Diagnostics Non-Invasive Prenatal Testing Introduction
11.6.4 Quest Diagnostics Revenue in Non-Invasive Prenatal Testing Business (2018-2023)
11.6.5 Quest Diagnostics Recent Developments
11.7 Illumina
11.7.1 Illumina Company Details
11.7.2 Illumina Business Overview
11.7.3 Illumina Non-Invasive Prenatal Testing Introduction
11.7.4 Illumina Revenue in Non-Invasive Prenatal Testing Business (2018-2023)
11.7.5 Illumina Recent Developments
11.8 Berry Genomics
11.8.1 Berry Genomics Company Details
11.8.2 Berry Genomics Business Overview
11.8.3 Berry Genomics Non-Invasive Prenatal Testing Introduction
11.8.4 Berry Genomics Revenue in Non-Invasive Prenatal Testing Business (2018-2023)
11.8.5 Berry Genomics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Sequenom
Roche
Natera
LabCorp
BGI Genomics
Quest Diagnostics
Illumina Inc
Berry Genomics
List of Tables
    Table 1. Global Non-Invasive Prenatal Testing Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
    Table 2. Key Players of High & Average Risk
    Table 3. Key Players of Low Risk
    Table 4. Global Non-Invasive Prenatal Testing Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
    Table 5. Global Non-Invasive Prenatal Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global Non-Invasive Prenatal Testing Market Size by Region (2018-2023) & (US$ Million)
    Table 7. Global Non-Invasive Prenatal Testing Market Share by Region (2018-2023)
    Table 8. Global Non-Invasive Prenatal Testing Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 9. Global Non-Invasive Prenatal Testing Market Share by Region (2024-2029)
    Table 10. Non-Invasive Prenatal Testing Market Trends
    Table 11. Non-Invasive Prenatal Testing Market Drivers
    Table 12. Non-Invasive Prenatal Testing Market Challenges
    Table 13. Non-Invasive Prenatal Testing Market Restraints
    Table 14. Global Non-Invasive Prenatal Testing Revenue by Players (2018-2023) & (US$ Million)
    Table 15. Global Non-Invasive Prenatal Testing Revenue Share by Players (2018-2023)
    Table 16. Global Top Non-Invasive Prenatal Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Prenatal Testing as of 2022)
    Table 17. Global Non-Invasive Prenatal Testing Industry Ranking 2021 VS 2022 VS 2023
    Table 18. Global 5 Largest Players Market Share by Non-Invasive Prenatal Testing Revenue (CR5 and HHI) & (2018-2023)
    Table 19. Global Key Players of Non-Invasive Prenatal Testing, Headquarters and Area Served
    Table 20. Global Key Players of Non-Invasive Prenatal Testing, Product and Application
    Table 21. Global Key Players of Non-Invasive Prenatal Testing, Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Non-Invasive Prenatal Testing Market Size by Type (2018-2023) & (US$ Million)
    Table 24. Global Non-Invasive Prenatal Testing Revenue Market Share by Type (2018-2023)
    Table 25. Global Non-Invasive Prenatal Testing Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 26. Global Non-Invasive Prenatal Testing Revenue Market Share by Type (2024-2029)
    Table 27. Global Non-Invasive Prenatal Testing Market Size by Application (2018-2023) & (US$ Million)
    Table 28. Global Non-Invasive Prenatal Testing Revenue Share by Application (2018-2023)
    Table 29. Global Non-Invasive Prenatal Testing Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 30. Global Non-Invasive Prenatal Testing Revenue Share by Application (2024-2029)
    Table 31. North America Non-Invasive Prenatal Testing Market Size by Type (2018-2023) & (US$ Million)
    Table 32. North America Non-Invasive Prenatal Testing Market Size by Type (2024-2029) & (US$ Million)
    Table 33. North America Non-Invasive Prenatal Testing Market Size by Application (2018-2023) & (US$ Million)
    Table 34. North America Non-Invasive Prenatal Testing Market Size by Application (2024-2029) & (US$ Million)
    Table 35. North America Non-Invasive Prenatal Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 36. North America Non-Invasive Prenatal Testing Market Size by Country (2018-2023) & (US$ Million)
    Table 37. North America Non-Invasive Prenatal Testing Market Size by Country (2024-2029) & (US$ Million)
    Table 38. Europe Non-Invasive Prenatal Testing Market Size by Type (2018-2023) & (US$ Million)
    Table 39. Europe Non-Invasive Prenatal Testing Market Size by Type (2024-2029) & (US$ Million)
    Table 40. Europe Non-Invasive Prenatal Testing Market Size by Application (2018-2023) & (US$ Million)
    Table 41. Europe Non-Invasive Prenatal Testing Market Size by Application (2024-2029) & (US$ Million)
    Table 42. Europe Non-Invasive Prenatal Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 43. Europe Non-Invasive Prenatal Testing Market Size by Country (2018-2023) & (US$ Million)
    Table 44. Europe Non-Invasive Prenatal Testing Market Size by Country (2024-2029) & (US$ Million)
    Table 45. China Non-Invasive Prenatal Testing Market Size by Type (2018-2023) & (US$ Million)
    Table 46. China Non-Invasive Prenatal Testing Market Size by Type (2024-2029) & (US$ Million)
    Table 47. China Non-Invasive Prenatal Testing Market Size by Application (2018-2023) & (US$ Million)
    Table 48. China Non-Invasive Prenatal Testing Market Size by Application (2024-2029) & (US$ Million)
    Table 49. Asia Non-Invasive Prenatal Testing Market Size by Type (2018-2023) & (US$ Million)
    Table 50. Asia Non-Invasive Prenatal Testing Market Size by Type (2024-2029) & (US$ Million)
    Table 51. Asia Non-Invasive Prenatal Testing Market Size by Application (2018-2023) & (US$ Million)
    Table 52. Asia Non-Invasive Prenatal Testing Market Size by Application (2024-2029) & (US$ Million)
    Table 53. Asia Non-Invasive Prenatal Testing Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 54. Asia Non-Invasive Prenatal Testing Market Size by Region (2018-2023) & (US$ Million)
    Table 55. Asia Non-Invasive Prenatal Testing Market Size by Region (2024-2029) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America Non-Invasive Prenatal Testing Market Size by Type (2018-2023) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Non-Invasive Prenatal Testing Market Size by Type (2024-2029) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Non-Invasive Prenatal Testing Market Size by Application (2018-2023) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Non-Invasive Prenatal Testing Market Size by Application (2024-2029) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Non-Invasive Prenatal Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 61. Middle East, Africa, and Latin America Non-Invasive Prenatal Testing Market Size by Country (2018-2023) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Non-Invasive Prenatal Testing Market Size by Country (2024-2029) & (US$ Million)
    Table 63. Sequenom Company Details
    Table 64. Sequenom Business Overview
    Table 65. Sequenom Non-Invasive Prenatal Testing Product
    Table 66. Sequenom Revenue in Non-Invasive Prenatal Testing Business (2018-2023) & (US$ Million)
    Table 67. Sequenom Recent Developments
    Table 68. Roche Company Details
    Table 69. Roche Business Overview
    Table 70. Roche Non-Invasive Prenatal Testing Product
    Table 71. Roche Revenue in Non-Invasive Prenatal Testing Business (2018-2023) & (US$ Million)
    Table 72. Roche Recent Developments
    Table 73. Natera Company Details
    Table 74. Natera Business Overview
    Table 75. Natera Non-Invasive Prenatal Testing Product
    Table 76. Natera Revenue in Non-Invasive Prenatal Testing Business (2018-2023) & (US$ Million)
    Table 77. Natera Recent Developments
    Table 78. LabCorp Company Details
    Table 79. LabCorp Business Overview
    Table 80. LabCorp Non-Invasive Prenatal Testing Product
    Table 81. LabCorp Revenue in Non-Invasive Prenatal Testing Business (2018-2023) & (US$ Million)
    Table 82. LabCorp Recent Developments
    Table 83. BGI Genomics Company Details
    Table 84. BGI Genomics Business Overview
    Table 85. BGI Genomics Non-Invasive Prenatal Testing Product
    Table 86. BGI Genomics Revenue in Non-Invasive Prenatal Testing Business (2018-2023) & (US$ Million)
    Table 87. BGI Genomics Recent Developments
    Table 88. Quest Diagnostics Company Details
    Table 89. Quest Diagnostics Business Overview
    Table 90. Quest Diagnostics Non-Invasive Prenatal Testing Product
    Table 91. Quest Diagnostics Revenue in Non-Invasive Prenatal Testing Business (2018-2023) & (US$ Million)
    Table 92. Quest Diagnostics Recent Developments
    Table 93. Illumina Company Details
    Table 94. Illumina Business Overview
    Table 95. Illumina Non-Invasive Prenatal Testing Product
    Table 96. Illumina Revenue in Non-Invasive Prenatal Testing Business (2018-2023) & (US$ Million)
    Table 97. Illumina Recent Developments
    Table 98. Berry Genomics Company Details
    Table 99. Berry Genomics Business Overview
    Table 100. Berry Genomics Non-Invasive Prenatal Testing Product
    Table 101. Berry Genomics Revenue in Non-Invasive Prenatal Testing Business (2018-2023) & (US$ Million)
    Table 102. Berry Genomics Recent Developments
    Table 103. Research Programs/Design for This Report
    Table 104. Key Data Information from Secondary Sources
    Table 105. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Non-Invasive Prenatal Testing Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 2. Global Non-Invasive Prenatal Testing Market Share by Type: 2022 VS 2029
    Figure 3. High & Average Risk Features
    Figure 4. Low Risk Features
    Figure 5. Global Non-Invasive Prenatal Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 6. Global Non-Invasive Prenatal Testing Market Share by Application: 2022 VS 2029
    Figure 7. 0-12 Weeks Case Studies
    Figure 8. 13-24 Weeks Case Studies
    Figure 9. 25-36 Weeks Case Studies
    Figure 10. Non-Invasive Prenatal Testing Report Years Considered
    Figure 11. Global Non-Invasive Prenatal Testing Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 12. Global Non-Invasive Prenatal Testing Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 13. Global Non-Invasive Prenatal Testing Market Share by Region: 2022 VS 2029
    Figure 14. Global Non-Invasive Prenatal Testing Market Share by Players in 2022
    Figure 15. Global Top Non-Invasive Prenatal Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Prenatal Testing as of 2022)
    Figure 16. The Top 10 and 5 Players Market Share by Non-Invasive Prenatal Testing Revenue in 2022
    Figure 17. North America Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 18. North America Non-Invasive Prenatal Testing Market Share by Type (2018-2029)
    Figure 19. North America Non-Invasive Prenatal Testing Market Share by Application (2018-2029)
    Figure 20. North America Non-Invasive Prenatal Testing Market Share by Country (2018-2029)
    Figure 21. United States Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. Canada Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. Europe Non-Invasive Prenatal Testing Market Size YoY (2018-2029) & (US$ Million)
    Figure 24. Europe Non-Invasive Prenatal Testing Market Share by Type (2018-2029)
    Figure 25. Europe Non-Invasive Prenatal Testing Market Share by Application (2018-2029)
    Figure 26. Europe Non-Invasive Prenatal Testing Market Share by Country (2018-2029)
    Figure 27. Germany Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. France Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. U.K. Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Italy Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Russia Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Nordic Countries Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. China Non-Invasive Prenatal Testing Market Size YoY (2018-2029) & (US$ Million)
    Figure 34. China Non-Invasive Prenatal Testing Market Share by Type (2018-2029)
    Figure 35. China Non-Invasive Prenatal Testing Market Share by Application (2018-2029)
    Figure 36. Asia Non-Invasive Prenatal Testing Market Size YoY (2018-2029) & (US$ Million)
    Figure 37. Asia Non-Invasive Prenatal Testing Market Share by Type (2018-2029)
    Figure 38. Asia Non-Invasive Prenatal Testing Market Share by Application (2018-2029)
    Figure 39. Asia Non-Invasive Prenatal Testing Market Share by Region (2018-2029)
    Figure 40. Japan Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. South Korea Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. China Taiwan Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Southeast Asia Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. India Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Australia Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Middle East, Africa, and Latin America Non-Invasive Prenatal Testing Market Size YoY (2018-2029) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Non-Invasive Prenatal Testing Market Share by Type (2018-2029)
    Figure 48. Middle East, Africa, and Latin America Non-Invasive Prenatal Testing Market Share by Application (2018-2029)
    Figure 49. Middle East, Africa, and Latin America Non-Invasive Prenatal Testing Market Share by Country (2018-2029)
    Figure 50. Brazil Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 51. Mexico Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 52. Turkey Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 53. Saudi Arabia Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 54. Israel Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 55. GCC Countries Non-Invasive Prenatal Testing Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 56. Sequenom Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2018-2023)
    Figure 57. Roche Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2018-2023)
    Figure 58. Natera Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2018-2023)
    Figure 59. LabCorp Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2018-2023)
    Figure 60. BGI Genomics Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2018-2023)
    Figure 61. Quest Diagnostics Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2018-2023)
    Figure 62. Illumina Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2018-2023)
    Figure 63. Berry Genomics Revenue Growth Rate in Non-Invasive Prenatal Testing Business (2018-2023)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions